disclosed Friday that Chief Financial Officer William “Bill” Chase plans to retire in mid-2019, and will be succeeded as CFO by Robert Michael effective Friday. The stock slipped 0.7% in morning trade. Chase has been appointed executive vice president of finance and administration, also effective Friday. Michael, how has been the biopharmaceutical company’s controller since March 1, 2017, will continue to report to Chase. Brian Durkin, who has been vice president of internal audit, was appointed controller. AbbVie’s stock has lost 7.7% year to date, while the S&P 500
has slipped 1.0%.
View more information: https://www.marketwatch.com/story/abbvie-cfo-bill-chase-to-retire-2018-10-19